ResearchMoz

Therapeutic Vaccines Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018

Transparency Market Research
 Therapeutic vaccines function by  triggering a body immune response against a disease. The global  therapeutic vaccines market was valued at USD 292 million in 2011. The  introduction of therapeutic vaccines has opened up new avenues in the  field of chronic disease treatment and prophylactic immunization.  Provenge was the first U.S. FDA approved immunotherapy drug to treat  prostate cancer in men in 2010, which has encouraged rigorous research  and development initiatives by pharmaceutical companies to develop novel  vaccines for untapped disease segments. As a result of these  initiatives, many more therapeutic vaccines are currently in the  pipeline such as breast cancer vaccine, lung cancer vaccine; Alzheimer’s  vaccine, malaria vaccine, and diabetes vaccine are expected to...
Table of content is not available for this report as it is upcoming report but you can specify you TOC requirement in our Request sample.

Upcoming Reports:

Poland: agricultural hand tools market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the agricultural hand tools market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the agricultural hand tools market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Rich Communications Suite Services And Subscribers Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Rich communication suite (RCS) service provides rich messaging and multimedia services for mobile subscribers. The increasing number of mobile phone users and the need for faster and effective multimedia communication are driving the market of rich communication suite services. Rich communication suite services support the RCS-enhanced variant of the standard to allow fast delivery of new services within the traditional contact list framework.  One of the major drivers of the RCS market is the increasing penetration levels of mobile subscribers in many regions, which is...
Vena Cava Filters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Inferior vena cava or posterior vena cava is the largest vein in the human body responsible for carrying de-oxygenated blood from the lower extremities of the body into the right atrium of heart and then to the lungs. Vena cava filter is a medical device designed to prevent blood clots from travelling to lungs. These filters are implanted by interventional radiologists or vascular surgeons and are used as prophylactic aid for pulmonary emboli. The two general types of vena cava filters are permanent and optionally retrievable filters. Such filters are surgically placed in the inferior...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:
  • Report will be delivered with in 15-20 working days.

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...